Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI

Coronary Artery Disease

Volumn 25, Issue 1, 2014, Pages 52-59

  Rathod, Krishnaraj S ^a   Jones, Daniel A ^a,b   Rathod, Vrijraj S ^a   Bromage, Daniel ^a   Guttmann, Oliver ^a   Gallagher, Sean M ^a   Mohiddin, Saidi ^a,b   Rothman, Martin T ^a   Knight, Charles ^a   Jain, Ajay K ^a   Kapur, Akhil ^a,b   Mathur, Anthony ^a,b   Timmis, Adam D ^a,b   Amersey, Rajiv ^a   Wragg, Andrew ^a,b  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

anaemia; major adverse cardiac events; myocardial infarction; primary percutaneous coronary intervention

Indexed keywords

HEMOGLOBIN;

ADULT; ADVERSE OUTCOME; AGED; ANEMIA; ARTICLE; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; LONDON; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890564671     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000038     Document Type: Article

References (21)

1. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2007; 28:1598-1660.
2. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, et al. Association of haemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111:2042-2049.
3. McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110:271-277.
4. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Gensini GF. Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? Intern Emerg Med 2010; 6:329-336.
5. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 2003:1815-1823.
6. Bassand JP. Impact of anaemia, bleeding and transfusions in acute coronary syndromes: a shift in the paradigm. Eur Heart J 2007; 28:1273-1274.
7. Al Falluji N, Lawrence-Nelson J, Kostis J, Lacy CR, Ranjan R, Wilson AC, et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144:636-641.
8. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 2004; 44:547-553.
9. Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD. Anaemia and prognosis in acute coronary syndromes: a systematic review and meta-analysis. J Int Med Res 2012; 40:43-55.
10. Moscucci M. Anemia and blood transfusion: prognostic implications in patients undergoing contemporary percutaneous coronary intervention. Curr Cardiol Rep 2009; 11:363-368.
11. Sulaiman K, Prashanth P, Al-Zakwani I, Al-Mahmeed W, Al-Motarreb A, Al Suwaidi J, et al. Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East. Clin Med Res 2012; 10:65-71.
12. WHO. Worldwide prevalence of anaemia 1993-2005. Geneva: World Health Organization; 2008.
13. Shah AD, Nicholas O, Timmis AD, Feder G, Abrams KR, Chen R, et al. Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med 2011; 8:e1000439.
14. Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010; 15:1385-1394.
15. Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, Wichter T, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24:2142-2150.
16. Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Levin-Iaina N, Iaina A, Dobrzycki S. Prevalence of chronic kidney disease and anemia in patients with coronary artery disease with normal serum creatinine undergoing percutaneous coronary interventions: relation to New York Heart Association class. Isr Med Assoc J 2010; 12:489-493.
17. Dündar C, Oduncu V, Erkol A, Tanalp AC, Srma D, Karagöz A, et al. In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol 2012; 101:37-44.
18. Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, et al. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2011; 107:849-856.
19. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994; 330:1119-1124.
20. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165:2214-2220.
21. Voors A. A single bolus of erythropoietin does not improve cardiac function after an acute myocardial infarction: results from the HEBE III trial. Oral communication at the 2010 ESC Congress Stockholm; 2010. Available at: http://www.escardio.org/about/press//press-releases/esc10-stockholm/pages/ hli-voors-hebe-iii-trial.aspx. [Accessed 10 July 2012].